Pharmaceutical Cold Chain Logistics Market: CCT Cuts Reships 84% and Launches Smaller Reusable Shipper

Pharmaceutical Cold Chain Logistics Market size reached US$ 22.75 Billion in 2025 and is expected to grow US$ 44.1 Billion by 2033, growing at a CAGR of 9.12% during the forecast period 2026-2033

DataM Intelligence has released its latest "Pharmaceutical Cold Chain Logistics Market Size 2026" report, delivering comprehensive insights into market trends, growth opportunities, competitive dynamics, and regional performance. The report covers market size by value and volume, CAGR forecasts, and emerging opportunities, the report delivers data-driven insights into industry developments, competitive trends, and future market outlook, enabling more effective strategic planning and market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/pharmaceutical-cold-chain-logistics-market?kb

United States: Recent Industry Developments

✅ July 2026: FedEx launched FedEx Life Sciences, a dedicated organization focused on pharmaceuticals, biologics, clinical trials, medical devices, and temperature-sensitive healthcare shipments.

✅ June 2026: UPS Healthcare announced a $48 million investment in 27 temperature-controlled freight cross-dock facilities across key global markets, strengthening cold-chain support for advanced therapies and temperature-sensitive medicines.

✅ February 2026: DHL expanded its dedicated pharmaceutical airfreight cold-chain network, adding temperature-controlled capacity and connecting major healthcare markets through more than 30 GDP-compliant aviation hubs and gateways.

✅ January 2026: DHL Supply Chain completed a one-million-square-foot Life Sciences & Healthcare distribution center of excellence in Pennsylvania, strengthening specialized pharmaceutical logistics and temperature-controlled infrastructure in the U.S.

Find the right strategic partners to accelerate your business. Get started today:- https://www.datamintelligence.com/partner-identification-enquiry/pharmaceutical-cold-chain-logistics-market?kb

Cold Chain Technologies Delivers Major Vaccine Distribution Savings

• 84% Reduction in Reships: Cold Chain Technologies reduced a global vaccine manufacturer's reship rate from 1.9% to 0.3%, with zero temperature excursions across 20,000 shipments.

• $12 Million in Cost Savings: The CCT thermal assurance program generated approximately $12 million in savings through reduced product losses, optimized freight decisions and improved packaging selection.

• 907,000 kg of Waste Avoided: Reusable CCT EcoFlex shippers and the CCT ReNew reverse logistics service prevented more than 2 million pounds (907,000 kg) of material from reaching landfill.

• Real-Time Cold Chain Intelligence: CCT C.A.R.E. and MedAssure combined 24/7 monitoring, predictive analytics and shipment intervention capabilities to improve vaccine distribution reliability and patient outcomes.

Top List of Key Player:

Cardinal Health, AmerisourceBergen Corporation, Envirotainer AB, FedEx, United Parcel Service of America, Inc., Thermo King, Sonoco ThermoSafe, B Medical Systems India Private Limited, DoKaSch TEMPERATURE SOLUTIONS GmbH, and Nordic Cold Chain Solutions

Key Industry Developments 2026:

The pharmaceutical cold chain logistics market is advancing as logistics providers and pharmaceutical companies invest in temperature-controlled infrastructure, specialized transportation, digital monitoring, and cold storage capabilities.

✅ July 2026: DHL Supply Chain expanded its pharmaceutical logistics capabilities by investing in temperature-controlled infrastructure and specialized healthcare logistics solutions to support the distribution of temperature-sensitive medicines and biologics.

✅ June 2026: UPS Healthcare strengthened its cold chain logistics network through expanded temperature-controlled facilities and healthcare transportation capabilities, supporting pharmaceutical manufacturers with reliable storage and distribution for sensitive products.

✅ May 2026: FedEx expanded its healthcare logistics solutions with enhanced cold chain capabilities, focusing on temperature monitoring, specialized packaging, and time-sensitive transportation for pharmaceuticals and biologics.

✅ April 2026: Kuehne+Nagel advanced its pharmaceutical logistics services by strengthening temperature-controlled transportation and storage capabilities to support the growing global distribution requirements of vaccines, biologics, and specialty medicines.

✅ March 2026: World Courier expanded its specialized pharmaceutical logistics infrastructure, strengthening temperature-controlled shipment capabilities for clinical trials, cell and gene therapies, and other temperature-sensitive healthcare products.

✅ February 2026: Marken continued expanding its healthcare logistics network and specialized cold chain services to support pharmaceutical and clinical trial shipments requiring controlled temperature conditions and real-time shipment visibility.

✅ January 2026: DB Schenker strengthened its healthcare logistics portfolio by expanding temperature-controlled supply chain solutions designed to improve pharmaceutical storage, transportation, and distribution across international markets.

How Our Market Research Process Works 2026-2033:

The Pharmaceutical Cold Chain Logistics Market report by DataM Intelligence delivers comprehensive insights backed by extensive primary and secondary research. It analyzes key market trends, competitive dynamics, regulatory developments, technological advancements, emerging innovations, and growth opportunities while highlighting potential challenges and evolving market conditions. The report provides actionable intelligence to support strategic planning and identify future market potential.

Latest M & A/ partnerships in 2026:

• June 15, 2026: Constellation Cold Logistics announced the proposed acquisition of Locagel and Transfreeze, expanding its French temperature-controlled storage and refrigerated transport network.

• May 27, 2026: RealCold acquired SCL Cold Chain, gaining CEIV Pharma-certified capabilities, FDA-registered facilities, continuous temperature monitoring and pharmaceutical chain-of-custody logistics expertise.

• April 16, 2026: PHSE Group acquired The Courier Company (UK) Ltd, strengthening its UK radiopharmaceutical logistics network and temperature-controlled, time-critical delivery capabilities.

• April 7, 2026: SK Pharma Logistics merged with Med-X-Press Group, creating a DACH healthcare logistics platform with 7 locations, 590+ employees and temperature-controlled pharmaceutical warehousing capacity.

• April 30, 2026: Greenbriar Equity Group completed the acquisition of AIT Worldwide Logistics, expanding its supply-chain platform serving life sciences and other specialized industries.

Buy Now & Unlock 360° Complete Market Insights: https://www.datamintelligence.com/buy-now-page?report=pharmaceutical-cold-chain-logistics-market?kb

Japan: Recent Industry Developments

✅ June 2026: DHL Supply Chain Japan and Toho Holdings signed an MOU to develop an advanced healthcare logistics platform combining Toho's domestic pharmaceutical distribution network with DHL's specialized healthcare logistics capabilities.

✅ February 2026: Takeda, Mitsubishi Logistics, and JR Freight introduced Japan's first 31-foot temperature-controlled rail containers for pharmaceutical transportation, expanding GDP-compliant capacity and supporting a shift from road to rail.

✅ January 2026: Takeda expanded temperature-controlled pharmaceutical rail transportation into the Tohoku region, helping bring approximately 60% of targeted pharmaceutical transport areas, by weight, onto rail and supporting an estimated 58% reduction in GHG emissions on converted routes.

✅ January 2026: Mitsubishi Logistics continued advancing its pharmaceutical logistics infrastructure, including GDP-compliant refrigerated delivery, temperature monitoring, traceability, and validated transportation services across Japan.

Key Segmentation Plannings (2026):

By Product Type: Vaccines, Biopharmaceuticals, Drugs, and Medicines

By Service Type: Storage, Transportation, Packaging, and Others

By Temperature Range: Frozen (Below -20°C), Refrigerated (2°C to 8°C), Ambient (15°C to 25°C), and Cryogenic (-150°C)

By Mode of Delivery: Last-Mile Delivery and Hubs-to-Distributor

By End-User: Pharmaceutical and Biopharmaceutical Companies, Biotechnology Companies, Hospitals and Healthcare Facilities, and Others

Global Market Growth Regional Analysis:

⇥ North merica (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Cold Chain Technologies Expands Reusable Shipping Portfolio

• EcoFlex XS Launch: Cold Chain Technologies introduced EcoFlex XS, a 3-liter reusable shipper designed for clinical trial samples, pharmaceutical products, blood and diagnostic shipments.

• Up to 96-Hour Thermal Performance: EcoFlex XS achieved up to 96 hours refrigerated, 89.7 hours controlled room temperature, and 66.2 hours frozen performance in ISTA 7D testing.

• 25.64% Smaller & 25.4% Lighter: Compared with the existing EcoFlex Small, the new shipper reduces volume by 25.64% and weight by 25.4%, helping lower freight costs.

• Three Temperature Ranges: The new CCT EcoFlex XS supports refrigerated (RFG), controlled room temperature (CRT), and frozen (FRG) applications while meeting ISTA 3A physical testing requirements.

Request a Customized Market Report Today:- https://www.datamintelligence.com/customize/pharmaceutical-cold-chain-logistics-market?kb

Market Drivers

• Rising Demand for Biologics & Specialty Drugs: Growing use of biologics, vaccines, GLP-1 drugs, and specialty injectables is increasing the need for reliable temperature-controlled logistics.

• Expansion of Vaccine & Immunization Programs: Continued vaccination initiatives are increasing the volume of temperature-sensitive pharmaceutical products requiring validated storage, transportation, and monitoring.

• Stricter Cold Chain Compliance: Stronger GDP requirements, temperature monitoring, documentation, and quality controls are pushing pharmaceutical companies toward specialized cold-chain logistics providers.

• Adoption of Real-Time Monitoring Technologies: IoT sensors, digital tracking, and automated temperature monitoring are improving shipment visibility, reducing temperature excursions, and protecting high-value medicines.

FAQ's

Q1: What is the current market size of the Pharmaceutical Cold Chain Logistics Market and its future outlook?

Ans: The global Pharmaceutical Cold Chain Logistics Market reached US$ 22.75 Billion in 2025 and is forecast to attain US$ 44.1 Billion by 2033

Q2: How fast is the Pharmaceutical Cold Chain Logistics Market expected to grow during the forecast period?

Ans: The market is projected to expand at a CAGR of 9.12% from 2025 to 2033, reflecting strong growth potential over the forecast period.

Q3: Which region leads the Pharmaceutical Cold Chain Logistics Market?

Ans: North America accounted for the largest market share, contributing 42.87% in 2025

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.